ClC-3 Chloride Channel

ClC-3 Chloride Channel

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ClC-3 Chloride Channel</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>ClC-3 Chloride Channel</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>CLCN3</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>P51790</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~84 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Synaptic vesicles, endosomes, lysosomes</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>CLC chloride channel family</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Brain (high), heart, kidney, liver</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Introduction

Clc 3 Chloride Channel is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

[@weinert2010]

ClC-3 (Chloride Channel Protein 3) is a voltage-gated chloride channel belonging to the CLC chloride channel family, with critical intracellular localization in synaptic vesicles, endosomes, and lysosomes Citation needed. It is widely expressed in the nervous system and plays essential roles in neuronal function, synaptic transmission, and cellular homeostasis Citation needed. [@stauber2012]

Overview

...

ClC-3 Chloride Channel

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ClC-3 Chloride Channel</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>ClC-3 Chloride Channel</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>CLCN3</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>P51790</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~84 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Synaptic vesicles, endosomes, lysosomes</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>CLC chloride channel family</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Brain (high), heart, kidney, liver</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Introduction

Clc 3 Chloride Channel is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

[@weinert2010]

ClC-3 (Chloride Channel Protein 3) is a voltage-gated chloride channel belonging to the CLC chloride channel family, with critical intracellular localization in synaptic vesicles, endosomes, and lysosomes Citation needed. It is widely expressed in the nervous system and plays essential roles in neuronal function, synaptic transmission, and cellular homeostasis Citation needed. [@stauber2012]

Overview

CLCN5 (Chloride Voltage-Gated Channel 5) is a gene located on chromosome Xq11.23. The encoded protein is a voltage-gated chloride channel involved in cellular ion homeostasis, acidification of intracellular compartments, and neuronal function. CLCN5 mutations are associated with neurodegenerative diseases and lysosomal storage disorders. [@marger2011]

Basic Information

Structure

ClC-3 shares the canonical CLC channel architecture with distinctive features [Citation needed]:

• 18 transmembrane helices organized into alpha and beta domains
• Dimeric assembly forming two independent chloride conduction pathways
• Conserved gating glutamate (E166) essential for Cl-/H+ antiport mechanism
• N-terminal domain with potential regulatory functions
• C-terminal dimerization domain critical for proper trafficking

The dimeric structure is essential for channel function, with each monomer forming its own pore Citation needed.

Normal Function

Expression Pattern

ClC-3 exhibits high expression in the nervous system [Citation needed]:

• Brain: Highest expression in [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), and cerebellum
• Synaptic vesicles: Highly enriched in presynaptic terminals
• Endosomes: Broad intracellular distribution
• Peripheral tissues: Moderate expression in heart, kidney, liver

Cellular Localization

ClC-3 is primarily an intracellular channel [Citation needed]:

• Synaptic vesicles: Major site of localization in [neurons](/entities/neurons)
• Endosomes: Early and recycling endosomes
• Lysosomes: Partial localization
• Plasma membrane: Minor fraction in some cell types

Physiological Roles

ClC-3 serves critical physiological functions [Citation needed]:

Synaptic vesicle acidification: Provides counter-transport for V-ATPase function

Neurotransmitter loading: Essential for synaptic vesicle chloride homeostasis

Synaptic transmission: Regulates vesicle release and recycling

Endosomal function: Maintains endosomal chloride concentration

Cellular homeostasis: Protects against osmotic stress

Neuronal survival: Important for neuronal health and function

Role in Disease

Neurodegeneration

ClC-3 dysfunction has been implicated in several neurodegenerative conditions [Citation needed]:

Alzheimer's Disease

• Altered ClC-3 expression in AD brain tissue Citation needed
• May affect [amyloid-beta](/proteins/amyloid-beta) processing through endosomal dysfunction Citation needed
• Potential role in synaptic vesicle defects in AD Citation needed

Parkinson's Disease

• ClC-3 variants associated with PD risk Citation needed
• May influence [alpha-synuclein](/mechanisms/alpha-synuclein) trafficking through endosomal pathways Citation needed
• Possible role in lysosomal dysfunction in PD Citation needed

Other Neurodegenerative Conditions

• Huntington's disease: Altered endosomal function Citation needed
• Amyotrophic lateral sclerosis (ALS): Motor neuron-specific effects Citation needed
• Epilepsy: Altered neuronal excitability Citation needed

Clinical Significance

Neurological Disorders

ClC-3-related neurological conditions [Citation needed]:

• Intellectual disability: Associated with severe CLCN3 mutations
• Seizures: Due to altered synaptic function
• Movement disorders: Including ataxia and dystonia

Therapeutic Implications

Targeting ClC-3 presents therapeutic opportunities [Citation needed]:

Channel modulators: Small molecules to enhance or inhibit activity

Gene therapy: Viral delivery to restore proper function

Endosomal pathway enhancement: Boosting downstream trafficking

Synaptic function restoration: Targeting synaptic vesicle function

Research Directions

Unresolved Questions

Key questions remain about ClC-3 [Citation needed]:

What is the precise molecular mechanism of disease-causing mutations?

How does ClC-3 specifically contribute to different neurodegenerative diseases?

Can small molecule modulators be developed for clinical use?

What is the therapeutic window for ClC-3 targeting?

Emerging Research

Recent advances include [Citation needed]:

• Structural studies: Cryo-EM analysis of ClC-3 architecture
• Animal models: Knockout mice revealing essential functions
• iPSC models: Patient-derived neurons for disease modeling
• Electrophysiology: Detailed characterization of channel properties

See Also

• [Proteins/Clcn3-Protein](/proteins/clcn3-protein) — This page

Background

The study of Clc 3 Chloride Channel has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Related Pages

• CLCN3 Gene
• ClC-4 Chloride Channel
• ClC-6 Chloride Channel
• ClC-7 Chloride Channel
• Endosomal-Lysosomal Pathway
• [Synaptic Transmission](/mechanisms/synaptic-dysfunction)

References

[Jentsch TJ et al, (1999) (1999)](https://pubmed.ncbi.nlm.nih.gov/10099684/)

[Weinert S et al, (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20471947/)

[Stauber T et al, (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22094550/)

[Marger F et al, (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21219955/)

[Weinert S et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32078021/)